Tafenoquine receives regulatory approval in U.S. for prophylaxis of malaria and radical cure of Plasmodium vivax (Q56342047)
Jump to navigation
Jump to search
scholarly article by Kathrine R Tan & Jimee Hwang published 20 August 2018 in Journal of Travel Medicine
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tafenoquine receives regulatory approval in U.S. for prophylaxis of malaria and radical cure of Plasmodium vivax |
scholarly article by Kathrine R Tan & Jimee Hwang published 20 August 2018 in Journal of Travel Medicine |
Statements
Tafenoquine receives regulatory approval in U.S. for prophylaxis of malaria and radical cure of Plasmodium vivax (English)
0 references
20 August 2018
0 references